Status in Israel
Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Vial 10 ml x 10mg/2ml |
|
22688 | 26176, 26153 |
Dosage
For I.M. use. Intended for short-term use only, for up to a maximum of three consecutive days. Should not be used in subjects under 18 years of age.
Elderly patients (>60 years): The recommended starting dose is 2.5-5 mg, Depending on the patient clinical status.
See prescribing information for full details.
Indications
Rapid control of agitation and disturbed behaviors in patients with schizophrenia when oral therapy is not appropriate.
Contra-Indications
Known hypersensitivity to any ingredient of the product. Olanzapine is contraindicated in patients with known risk of narrow-angle glaucoma.
Manufacturer
Lilly Pharma, Germany
Licence holder